Quarterly report · Q1
2914.TEDINET S100TDT5
Period2024-01-01 → 2024-03-31
Filed2024-05-09
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥740.3bn | 2024-01-01 → 2024-03-31 | Cons. | Revenue IFRS |
| Revenue | ¥2.84T | 2023-01-01 → 2023-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥665.3bn | 2023-01-01 → 2023-03-31 | Cons. | Revenue IFRS |
| Operating income | ¥215.8bn | 2024-01-01 → 2024-03-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥206.4bn | 2023-01-01 → 2023-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥201.3bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥621.6bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥183.1bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥157.3bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥482.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥144.7bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥157.8bn | 2024-01-01 → 2024-03-31 | Cons. | Profit loss IFRS |
| Net income | ¥485.3bn | 2023-01-01 → 2023-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥145.2bn | 2023-01-01 → 2023-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥7.16T | at 2024-03-31 | Cons. | Assets IFRS |
| Total assets | ¥7.28T | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥6.35T | at 2023-03-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.09T | at 2024-03-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.37T | at 2023-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥4.07T | at 2024-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.91T | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.59T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥3.62T | at 2022-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥3.99T | at 2024-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥3.83T | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥766.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥1.04T | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥665.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥866.9bn | at 2022-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥61.8bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥567.0bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥55.7bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥27.7bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥126.1bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥41.7bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥341.2bn | 2024-01-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥270.5bn | 2023-01-01 → 2023-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥196.4bn | 2023-01-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥88.58 | 2024-01-01 → 2024-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥271.69 | 2023-01-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥81.52 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥88.57 | 2024-01-01 → 2024-03-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥271.63 | 2023-01-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥81.49 | 2023-01-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 55.7% | at 2024-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 52.6% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 55.3% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 68
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-01-01 → 2024-03-31 | ¥1.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-01-01 → 2024-03-31 | ¥322m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥705m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-03-31 | −¥11.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-03-31 | −¥11.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-01-01 → 2024-03-31 | −¥9.3bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-03-31 | −¥774m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-03-31 | −¥774m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | ¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | ¥24m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | ¥24m |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥23.3bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥23.3bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥3.8bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥3.8bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥3.8bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥35.7bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥35.7bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥6m |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥2.0bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥2.0bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥2.0bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥681.0bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥681.0bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥64m |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥231.9bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥231.9bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | segment profit | 2024-01-01 → 2024-03-31 | ¥219.2bn |
| —segment total | revenue | 2024-01-01 → 2024-03-31 | ¥740.1bn |
| —segment total | revenue external | 2024-01-01 → 2024-03-31 | ¥740.0bn |
| —segment total | revenue intersegment | 2024-01-01 → 2024-03-31 | ¥69m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥237.7bn |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥237.7bn |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | ¥225.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-03-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-03-31 | ¥443m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥654m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | −¥10.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | −¥10.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | −¥10.6bn |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | −¥723m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | −¥723m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | ¥8m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | ¥8m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | ¥8m |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥24.9bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥24.9bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥6.9bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥6.9bn |
| jpcrp040300-q1r_E00492-000Pharmaceuticalsreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥6.9bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥35.6bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥35.6bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥8m |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q1r_E00492-000Processed Foodreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥604.4bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥604.3bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥61m |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥225.1bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥225.1bn |
| jpcrp040300-q1r_E00492-000Tobaccoreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥208.8bn |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥664.9bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥664.8bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥69m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥233.5bn |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥233.5bn |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥217.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 891
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember | 6924000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember | 1315000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReportableSegmentsMember | 216994000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -10598000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReconcilingItemsMember | 8000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 206404000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 7483000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 30741000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 183146000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember | 231883000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember | 3842000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember | 2021000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 237746000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -11074000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | 24000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration | 226695000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember | 12952000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentYTDDuration_ReportableSegmentsMember | 12952000000 | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Amortization cost of acquired intangibles arising from business acquisitions IFRS | CurrentYTDDuration | 12952000000 | JPY |
| Adjustment items income IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember | 7000000 | JPY |
| Adjustment items income IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Adjustment items income IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember | － | JPY |
| Adjustment items income IFRS | CurrentYTDDuration_ReportableSegmentsMember | 7000000 | JPY |
| Adjustment items income IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 1956000000 | JPY |
| Adjustment items income IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Adjustment items income IFRS | CurrentYTDDuration | 1963000000 | JPY |
| Adjustment items costs IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember | -291000000 | JPY |
| Adjustment items costs IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember | － | JPY |
| Adjustment items costs IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember | 20000000 | JPY |
| Adjustment items costs IFRS | CurrentYTDDuration_ReportableSegmentsMember | -271000000 | JPY |
| Adjustment items costs IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 159000000 | JPY |
| Adjustment items costs IFRS | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Adjustment items costs IFRS | CurrentYTDDuration | -112000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000TobaccoReportableSegmentMember | 219229000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000PharmaceuticalsReportableSegmentMember | 3842000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_jpcrp040300-q1r_E00492-000ProcessedFoodReportableSegmentMember | 2001000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReportableSegmentsMember | 225072000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -9278000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | 24000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 215818000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 14877000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 29429000000 | JPY |
| Profit loss before tax IFRS | CurrentYTDDuration | 201266000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |